FDA Gives Metabolism/Endocrinology Division An Acting Director
This article was originally published in The Pink Sheet Daily
Executive Summary
Diabetes team leader Jean-Marc Guettier is detailed to replace Mary Parks as director of the Division of Metabolism and Endocrinology Products on a temporary basis as she moves up to Deputy Director of the Office of Drug Evaluation II.